MY ACCOUNT | NEWSLETTER |

Pet cannabis advocacy group backs CA bill


The Pet Cannabis Coalition, a group working toward the legalization of cannabis for pets and legislation that protects veterinarians recommending such treatment, was recently formed. The group has also thrown its support behind a proposed California law that would allow veterinarians in the state to suggest cannabis for pets without concern for disciplinary action. California Assembly Bill 1885 would protect veterinarians and allow them to recommend the substance for therapies or as supplements for certain animals. 

“Cannabis can provide life-changing, and oftentimes lifesaving, benefits for animals,” said Dr. Tim Shu, veterinarian, and president of the Pet Cannabis Coalition and founder and chief executive officer of a cannabis treatment company, VETCBD. 

“Pets and their owners deserve to have access to products that can improve their lives, and veterinarians should be allowed to provide guidance on such products. We need to shed the shroud of prohibition and embrace science if we're to embark on a path of progress. This is why we created the Pet Cannabis Coalition; to ensure there is staunch political advocacy surrounding the health and wellness of our beloved pets.”

Cannabis, and more specifically the active ingredient of cannabinoids, can reduce pain and discomfort from arthritis and improve effects of seizures. The substance is also thought to reduce anxiety, allergies, nausea, and pain.

A 2018 bill allowed veterinarians to discuss cannabis for pets with their owners. However, the law was vague and was thought to lead to reluctance to by veterinarians to directly recommend the use of such products. 


Like1
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Manoeuvring the innovative drug delivery systems for veterinary therapeutics: Present day demand

Like0
Dislike0

Stereotactic Radiation Therapy Planning, Dose Prescription and Delivery in Veterinary Medicine: A Systematic Review on Completeness of Reporting and Proposed Reporting Items

Like0
Dislike0

Management and medicine of backyard poultry

Like0
Dislike0

Horse makes immediate recovery following removal of large nasal mass

Like0
Dislike0

Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top